Physician profile

John Kelly

Family Medicine · Charleston, WV

NPI 1982618690

$706.20

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $211.71 2019-2020
Lilly USA, LLC $95.97 2019-2020
Janssen Pharmaceuticals, INC $58.12 2019
Novo Nordisk INC $52.81 2019-2020
Boehringer Ingelheim Pharmaceuticals, INC. $44.58 2019
Sanofi-Aventis U.S. LLC $37.37 2019-2021
Biodelivery Sciences International, INC. $37.24 2020
Teva Pharmaceuticals USA, INC. $31.11 2019-2020
Abbott Laboratories $17.94 2020
Amgen INC. $17.44 2020
Amarin Pharma, INC. $16.56 2019
Astellas Pharma US INC $16.10 2019
Merck Sharp & Dohme LLC $15.60 2019
Genentech USA, INC. $15.46 2019
Allergan, INC. $12.82 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $12.80 2019
Kowa Pharmaceuticals America, INC. $12.57 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John Kelly

$706.20

in general payments reported 2019-2025

Years
2019-2021
Top company
Astrazeneca Pharmaceuticals LP

https://glasscript.com/doctor/361800/john-kelly

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.